Genetic inactivation of GSK3α rescues spine deficits in Disc1-L100P mutant mice.

Abstract:

:Disrupted-in-Schizophrenia 1 (DISC1), a strong candidate gene for schizophrenia and other mental disorders, regulates neurodevelopmental processes including neurogenesis, neuronal migration, neurite outgrowth and spine development. Glycogen synthase kinase-3 (GSK3) directly interacts with DISC1 and also plays a role in neurodevelopment. Recently, our group showed that the Disc1-L100P mutant protein has reduced interaction with both GSK3α and β. Genetic and pharmacological inhibition of GSK3 activity rescued behavioral abnormalities in Disc1-L100P mutant mice. However, the cellular mechanisms mediating these effects of GSK3 inhibition in Disc1 mutant mice remain unclear. We sought to investigate the effects of genetic inactivation of GSK3α on frontal cortical neuron morphology in Disc1 L100P mutant mice using Golgi staining. We found a significant decrease in dendritic length and surface area in Disc1-L100P, GSK3α null and L100P/GSK3α double mutants. Dendritic spine density was significantly reduced only in Disc1-L100P and L100P/GSK3α +/- mice when compared to wild-type littermates. There was no difference in dendritic arborization between the various genotypes. No significant rescue in dendritic length and surface area was observed in L100P/GSK3α mutants versus L100P mice, but spine density in L100P/GSK3α mice was comparable to wild-type. Neurite outgrowth and spine development abnormalities induced by Disc1 mutation may be partially corrected through GSK3α inactivation, which also normalizes behavior. However, many of the other dendritic abnormalities in the Disc1-L100P mutant mice were not corrected by GSK3α inactivation, suggesting that only some of the anatomical defects have observable behavioral effects. These findings suggest novel treatment approaches for schizophrenia, and identify a histological read-out for testing other therapeutic interventions.

journal_name

Schizophr Res

journal_title

Schizophrenia research

authors

Lee FH,Kaidanovich-Beilin O,Roder JC,Woodgett JR,Wong AH

doi

10.1016/j.schres.2011.03.032

subject

Has Abstract

pub_date

2011-06-01 00:00:00

pages

74-9

issue

1

eissn

0920-9964

issn

1573-2509

pii

S0920-9964(11)00180-0

journal_volume

129

pub_type

杂志文章
  • Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia.

    abstract::Glutamate transporters facilitate the buffering, clearance and cycling of glutamate and play an important role in maintaining synaptic and extrasynaptic glutamate levels. Alterations in glutamate transporter expression may lead to abnormal glutamate neurotransmission contributing to the pathophysiology of schizophreni...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2012.12.019

    authors: Shan D,Lucas EK,Drummond JB,Haroutunian V,Meador-Woodruff JH,McCullumsmith RE

    更新日期:2013-03-01 00:00:00

  • Subjective quality of life in first-episode psychosis. A ten year follow-up study.

    abstract:UNLABELLED:Subjective quality of life (S-QoL) is an important outcome measure in first episode psychosis (FEP). The aims of this study were to describe S-QoL-development the first 10-years in FEP patients and to identify predictors of this development. METHODS:A representative sample of 272 patients with a first episo...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2016.02.034

    authors: Gardsjord ES,Romm KL,Friis S,Barder HE,Evensen J,Haahr U,ten Velden Hegelstad W,Joa I,Johannessen JO,Langeveld J,Larsen TK,Opjordsmoen S,Rund BR,Simonsen E,Vaglum P,McGlashan T,Melle I,Røssberg JI

    更新日期:2016-04-01 00:00:00

  • General intellectual ability does not explain the general deficit in schizophrenia.

    abstract::Patients with schizophrenia demonstrate a generalized deficit across multiple cognitive domains. However, it is unknown whether this deficit is largely due to lower intelligence, or if there is an impact of schizophrenia which cannot be accounted for by measures of general intellectual ability (GIA). We created four I...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2013.04.016

    authors: Gray BE,McMahon RP,Gold JM

    更新日期:2013-07-01 00:00:00

  • Factor structure of the Brief Negative Symptom Scale.

    abstract::The current study examined the factor structure of the Brief Negative Symptom Scale (BNSS), a next-generation negative symptom rating instrument developed in response to the NIMH-sponsored Consensus Development Conference on Negative Symptoms. Participants included 146 individuals with a DSM-IV diagnosis of schizophre...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2012.09.007

    authors: Strauss GP,Hong LE,Gold JM,Buchanan RW,McMahon RP,Keller WR,Fischer BA,Catalano LT,Culbreth AJ,Carpenter WT,Kirkpatrick B

    更新日期:2012-12-01 00:00:00

  • Lowered paraoxonase 1 (PON1) activity is associated with increased cytokine levels in drug naïve first episode psychosis.

    abstract:BACKGROUND:Activated immune-inflammatory pathways play an important role in the pathophysiology of schizophrenia. Paraoxonase 1 (PON1) activity is inversely associated with inflammatory responses in numerous clinical conditions. The aims of this study were to delineate serum arylesterase PON1 activity in drug-naïve fir...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2015.06.009

    authors: Brinholi FF,Noto C,Maes M,Bonifácio KL,Brietzke E,Ota VK,Gadelha A,Cordeiro Q,Belangero SI,Bressan RA,Vargas HO,Higachi L,de Farias CC,Moreira EG,Barbosa DS

    更新日期:2015-08-01 00:00:00

  • Impact of physical activity on functioning of patients with first-episode psychosis--a 6 months prospective longitudinal study.

    abstract::There has been increasing interest in studying the impact of physical activity on the psychological and physical well-being and functioning in patients with first-episode psychosis. The exploration of factors which contribute to physical activity in psychosis may open up opportunities for improvement of functional out...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2013.08.034

    authors: Lee EH,Hui CL,Chang WC,Chan SK,Li YK,Lee JT,Lin JJ,Chen EY

    更新日期:2013-11-01 00:00:00

  • The factor structure and clinical utility of formal thought disorder in first episode psychosis.

    abstract:BACKGROUND:Formal thought disorder (FTD) is a core feature of psychosis, however there are gaps in our knowledge about its prevalence and factor structure. We had two aims: first, to establish the factor structure of FTD; second, to explore the clinical utility of dimensions of FTD in order to further the understanding...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2015.07.049

    authors: Roche E,Lyne JP,O'Donoghue B,Segurado R,Kinsella A,Hannigan A,Kelly BD,Malone K,Clarke M

    更新日期:2015-10-01 00:00:00

  • Measuring neuroleptic-induced akathisia by three-channel actometry.

    abstract::Three-channel actometry was used to study neuroleptic-induced akathisia (NIA), a common and often serious disorder in association of traditional neuroleptic therapy. The aim was to explore the diagnostic possibilities of actometry in NIA and to examine in detail the motor phenomenology of the disorder in detail. The a...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(99)00045-6

    authors: Tuisku K,Lauerma H,Holi M,Markkula J,Rimon R

    更新日期:1999-11-30 00:00:00

  • Resequencing of the vesicular glutamate transporter 2 gene (VGLUT2) reveals some rare genetic variants that may increase the genetic burden in schizophrenia.

    abstract:OBJECTIVES:Vesicular glutamate transporters (VGLUT1-3) package glutamate into vesicles in the presynaptic terminal and regulate the release of glutamate. In mesencephalic dopamine neuron culture, the majority of isolated dopamine neurons express VGLUT2, but not VGLUT1 or 3, have been demonstrated. As related to the dys...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2010.05.015

    authors: Shen YC,Liao DL,Lu CL,Chen JY,Liou YJ,Chen TT,Chen CH

    更新日期:2010-08-01 00:00:00

  • Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment.

    abstract:PURPOSE:The excitatory neurotransmitter glutamate has become an important area of focus for schizophrenia researchers. Polymorphisms in the type-three metabotropic glutamate receptor gene (GRM3) have been associated with the pathogenesis of schizophrenia. The purpose of this study was to determine whether a pharmacogen...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2005.04.001

    authors: Bishop JR,Ellingrod VL,Moline J,Miller D

    更新日期:2005-09-15 00:00:00

  • A preliminary study of interactive questioning methods to assess and improve understanding of informed consent among patients with schizophrenia.

    abstract::Growing recognition of the inadequacy of traditional methods of providing informed consent, especially for individuals vulnerable to impaired decisional capacity, has spurred recent interest in how to assess and improve components of consent-related decision making. In this preliminary study, we aimed to compare diffe...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.schres.2004.06.009

    authors: Eyler LT,Mirzakhanian H,Jeste DV

    更新日期:2005-06-15 00:00:00

  • The occurrence of cancer in first admitted schizophrenic patients.

    abstract::The incidence of cancer was studied in a cohort of all first admitted 9156 patients in Denmark with a diagnosis of schizophrenia in the period 1970-1987. The overall incidence of cancer was reduced particularly in the males. Adjustment for the smoking habits of psychiatric patients enhanced this risk reduction. Fewer ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/0920-9964(94)90028-0

    authors: Mortensen PB

    更新日期:1994-06-01 00:00:00

  • MATRICS cognitive consensus battery (MCCB) performance in children, adolescents, and young adults.

    abstract:BACKGROUND:Neurodevelopmental models of schizophrenia suggest that cognitive deficits may be observed during childhood and adolescence, long before the onset of psychotic symptoms. Elucidating the trajectory of normal cognitive development during childhood and adolescence may therefore provide a basis for identifying s...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2013.11.023

    authors: Nitzburg GC,Derosse P,Burdick KE,Peters BD,Gopin CB,Malhotra AK

    更新日期:2014-01-01 00:00:00

  • A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effects.

    abstract::Prospective, double-blind, randomized trials comparing atypical antipsychotic drugs (APDs) to typical APDs, such as haloperidol, indicate that atypical APDs provide a modest benefit to cognitive function in schizophrenia. However, the validity of this inference has been contested by suggestions that the cognitive impr...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.schres.2006.08.021

    authors: Woodward ND,Purdon SE,Meltzer HY,Zald DH

    更新日期:2007-01-01 00:00:00

  • Decomposing P300 into correlates of genetic risk and current symptoms in schizophrenia: An inter-trial variability analysis.

    abstract:BACKGROUND:The P300 event-related potential (ERP) component, which reflects cognitive processing, is a candidate biomarker for schizophrenia. However, the role of P300 in the pathophysiology of schizophrenia remains unclear because averaged P300 amplitudes reflect both genetic predisposition and current clinical status...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2017.04.001

    authors: Kim M,Lee TH,Kim JH,Hong H,Lee TY,Lee Y,Salisbury DF,Kwon JS

    更新日期:2018-02-01 00:00:00

  • Verbal and visual memory: characterizing the clinical and intermediate phenotype in schizophrenia.

    abstract:BACKGROUND:Verbal and visual memory deficits are prominent trait markers for schizophrenia, with impairments also observed in first-degree relatives [Snitz, B.E., Macdonald, A.W., 3rd, & Carter, C.S. (2006). Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of put...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2008.05.027

    authors: Skelley SL,Goldberg TE,Egan MF,Weinberger DR,Gold JM

    更新日期:2008-10-01 00:00:00

  • High rates of comorbidity are found in childhood-onset schizophrenia.

    abstract:BACKGROUND:For adults with schizophrenia, comorbidity is common and contributes to impairment. Thus, there has been an increasing effort to identify and treat comorbid symptoms. This report extends that work by examining comorbidity in children and young adolescents with childhood-onset schizophrenia. METHODS:Eighty-t...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2006.07.006

    authors: Ross RG,Heinlein S,Tregellas H

    更新日期:2006-12-01 00:00:00

  • Neural correlates of reality filtering in schizophrenia spectrum disorder.

    abstract:BACKGROUND:A false sense of reality is a characteristic of schizophrenia spectrum disorders (SSD). Reality confusion may also emanate from posterior orbitofrontal cortex (OFC) lesions, as evident in confabulations that patients act upon and disorientation. This confusion can be measured by repeated runs of a continuous...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2018.07.036

    authors: Thézé R,Manuel AL,Pedrazzini E,Chantraine F,Patru MC,Nahum L,Guggisberg AG,Schnider A

    更新日期:2019-02-01 00:00:00

  • Baseline psychopathology and relationship to longitudinal functional outcome in attenuated and early first episode psychosis.

    abstract:BACKGROUND:As efforts intensify to intervene early among those at risk for psychosis, examination of the relationship between presenting psychopathology and long-term functional outcome may guide treatment decision-making and offer a means to prevent or reduce chronic disability. METHODS:Data were collected through th...

    journal_title:Schizophrenia research

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/j.schres.2019.07.048

    authors: Burton CZ,Tso IF,Carrión RE,Niendam T,Adelsheim S,Auther AM,Cornblatt BA,Carter CS,Melton R,Sale TG,Taylor SF,McFarlane WR

    更新日期:2019-10-01 00:00:00

  • Trajectories of the course of schizophrenia: from progressive deterioration to amelioration over three decades.

    abstract:BACKGROUND:The extent of heterogeneity in the long-term course of schizophrenia is unclear. AIMS:To examine the course of schizophrenia in a population-based cohort. METHODS:This study included all Israeli individuals born in 1970-1988, of North African or European origin (N=2290), entered in the National Psychiatric...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2010.10.026

    authors: Levine SZ,Lurie I,Kohn R,Levav I

    更新日期:2011-03-01 00:00:00

  • Does a parent-report measure of behavioral problems enhance prediction of conversion to psychosis in clinical high-risk adolescents?

    abstract::Recent research on risk for psychosis has focused on youth who manifest subclinical signs that are often associated with the prodrome to psychosis. Standardized measures of prodromal symptoms have been shown to significantly enhance prediction of risk for conversion to an Axis I psychotic disorder. In the present stud...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2011.03.034

    authors: Simeonova DI,Attalla A,Trotman H,Esterberg M,Walker EF

    更新日期:2011-08-01 00:00:00

  • Neurocognitive performance in children aged 9-12 years who present putative antecedents of schizophrenia.

    abstract:BACKGROUND:We previously developed a novel method of identifying children aged 9-12 years who may be at elevated risk of developing schizophrenia and the spectrum disorders because they present a triad of putative antecedents of schizophrenia (ASz). The present study aimed to determine whether ASz children also present...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2010.05.034

    authors: Cullen AE,Dickson H,West SA,Morris RG,Mould GL,Hodgins S,Murray RM,Laurens KR

    更新日期:2010-08-01 00:00:00

  • Computational approaches to schizophrenia: A perspective on negative symptoms.

    abstract::Schizophrenia is a heterogeneous spectrum disorder often associated with detrimental negative symptoms. In recent years, computational approaches to psychiatry have attracted growing attention. Negative symptoms have shown some overlap with general cognitive impairments and were also linked to impaired motivational pr...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,评审

    doi:10.1016/j.schres.2016.10.004

    authors: Deserno L,Heinz A,Schlagenhauf F

    更新日期:2017-08-01 00:00:00

  • Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode.

    abstract:BACKGROUND:Many patients recovering from a first psychotic episode will discontinue medication against medical advice, even before a 1-year treatment course is completed. Factors associated with treatment adherence in patients with chronic schizophrenia include beliefs about severity of illness and need for treatment, ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2005.10.016

    authors: Perkins DO,Johnson JL,Hamer RM,Zipursky RB,Keefe RS,Centorrhino F,Green AI,Glick IB,Kahn RS,Sharma T,Tohen M,McEvoy JP,Weiden PJ,Lieberman JA,HGDH Research Group.

    更新日期:2006-03-01 00:00:00

  • An Interleukin-1 beta (IL1B) haplotype linked with psychosis transition is associated with IL1B gene expression and brain structure.

    abstract::We investigated IL1B genetic variation previously associated with risk for transition to psychosis for its association with gene expression in human post-mortem dorsolateral prefrontal cortex (DLPFC) from 74 (37 schizophrenia, 37 control) individuals and brain structure in 92 (44 schizophrenia, 48 control) living indi...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2018.09.008

    authors: Mostaid MS,Dimitrakopoulos S,Wannan C,Cropley V,Weickert CS,Everall IP,Pantelis C,Bousman CA

    更新日期:2019-02-01 00:00:00

  • Adolescent developmental change in topography of EEG amplitude.

    abstract::EEGs were recorded from 32 channels in 30 normal males, ages 16-22. Delta activity decreased throughout this age range. This decrease was greatest in the left frontal and temporal regions; no occipital lead showed this pattern. Relative EEG amplitude analysis, based on normalized maps, revealed decreases with age acro...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/0920-9964(92)90039-8

    authors: Buchsbaum MS,Mansour CS,Teng DG,Zia AD,Siegel BV Jr,Rice DM

    更新日期:1992-07-01 00:00:00

  • Potential stigma associated with inclusion of the psychosis risk syndrome in the DSM-V: an empirical question.

    abstract::While the "clinical high-risk state" for psychosis has demonstrated good reliability and fair predictive validity for psychotic disorders, over 50% of identified subjects do not progress to psychosis. Despite the benefits that early detection and treatment might offer, debate concerning the official inclusion of a "ps...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2010.03.012

    authors: Yang LH,Wonpat-Borja AJ,Opler MG,Corcoran CM

    更新日期:2010-07-01 00:00:00

  • Schizotypal dimensions: continuity between schizophrenia and bipolar disorders.

    abstract:BACKGROUND:Family studies have suggested that schizophrenia and bipolar disorders share some susceptibility factors. Schizotypal personality disorder (SPD) may be an intermediate phenotype common both to schizophrenia and bipolar disorders. We explored the familiality of schizotypal dimensions by comparing the magnitud...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2005.07.009

    authors: Schürhoff F,Laguerre A,Szöke A,Méary A,Leboyer M

    更新日期:2005-12-15 00:00:00

  • A novel approach to measuring response and remission in schizophrenia in clinical trials.

    abstract:BACKGROUND:Pharmaceutical companies conduct clinical trials to show the efficacy and safety of new medications for the treatment of schizophrenia. After the new medications are marketed, clinicians treating patients with schizophrenia discover that a considerable number of patients do not respond to these new medicatio...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,评审

    doi:10.1016/j.schres.2017.03.020

    authors: Aboraya A,Leucht S,Nasrallah HA,Samara M,Haro JM,Elshazly A,Zangeneh M

    更新日期:2017-12-01 00:00:00

  • Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2.

    abstract::Mismatch negativity (MMN) and P3a are auditory event-related potential (ERP) components that show robust deficits in schizophrenia (SZ) patients and exhibit qualities of endophenotypes, including substantial heritability, test-retest reliability, and trait-like stability. These measures also fulfill criteria for use a...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.schres.2014.09.042

    authors: Light GA,Swerdlow NR,Thomas ML,Calkins ME,Green MF,Greenwood TA,Gur RE,Gur RC,Lazzeroni LC,Nuechterlein KH,Pela M,Radant AD,Seidman LJ,Sharp RF,Siever LJ,Silverman JM,Sprock J,Stone WS,Sugar CA,Tsuang DW,Tsuang MT

    更新日期:2015-04-01 00:00:00